Gene57504
MTA3: metastasis associated 1 family member 3
Cite this record
ConductScience Library. MTA3: metastasis associated 1 family member 3. Genes, record 57504. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/57504
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9BTC8 | Metastasis-associated protein MTA3 | 594 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents41
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260201011 A1 | 2026-07-16 | 15314 | Q9BTC8 | Espacenet |
| US 20260125700 A1 | 2026-05-07 | 15314 | Q9BTC8 | Espacenet |
| US 20260125701 A1 | 2026-05-07 | 15314 | Q9BTC8 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 15314 | Q9BTC8 | Espacenet |
| US 12415844 B2 | 2025-09-16 | 15314 | Q9BTC8 | Espacenet |
| US 12385061 B2 | 2025-08-12 | 15314 | Q9BTC8 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 15314 | Q9BTC8 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 15314 | Q9BTC8 | Espacenet |
| US 20240398993 A1 | 2024-12-05 | 12126 | Q9BTC8 | Espacenet |
| US 20240285795 A1 | 2024-08-29 | 278977 | Q9BTC8 | Espacenet |
NIH grants506
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MTA3 papers | Newest fiscal year |
|---|---|---|---|
| ZIAES101965 | Eukaryotic Transcriptional Regulation | 13 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 4 | 2025 |
| R01CA072038 | Replication Stress and DNA Damage Response Drives ESR1 Mutant Metastasis | 3 | 2025 |
| P30CA022453 | CANCER CENTER SUPPORT GRANT | 2 | 2025 |
| P50CA058223 | SPORE in Breast Cancer | 2 | 2025 |
| R01CA198279 | Shaping DNA Damage Response Networks Via Histone H2A Variants | 2 | 2025 |
| T32CA148724 | Cancer Biology Training Program | 2 | 2025 |
| ZIABC006150 | DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs | 2 | 2025 |
| ZIABC011006 | Molecular diagnosis and outcome prediction in lymphoma | 2 | 2025 |
| ZICAG000616 | Analysis of complex biological systems by high-throughput genomic technologies | 2 | 2025 |
Source NIH's project files
Papers635
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical Significance of miR-3619-5p Expression in Patients with Type 2 Diabetes and Its Regulation of Pancreatic β-Cell Proliferation. | J Vis Exp | 2026 | 42813698 | PubTator, text mining | PubMed |
| Immunohistochemical Expression of Metastasis-Associated Gene 3 (MTA3) and Epithelial-Mesenchymal Transition (EMT) Markers in Colorectal Carcinoma: A Cross-sectional Study. | Iran J Pathol | 2026 | 42433320 | PubTator, text mining | PubMed |
| 3D chromatin architecture-related genes orchestrate LUAD evolution and therapy resistance: insights from integrative machine learning and spatial single-cell mapping. | Funct Integr Genomics | 2026 | 42240917 | PubTator, text mining | PubMed |
| SIX3 as a Regulator of Development and Disease. | J Dev Biol | 2026 | 41892811 | PubTator, text mining | PubMed |
| Allelic Variation at 9p21.3 Orchestrates Widespread RNA Splicing Shifts Governing Vascular Smooth Muscle Cell Plasticity. | bioRxiv | 2026 | 41648216 | PubTator, text mining | PubMed |
| Comparative multi-omics in female mice reveals tissue-specific vulnerabilities to chronic alcohol intake. | Alcohol Clin Exp Res (Hoboken) | 2026 | 41612900 | PubTator, text mining | PubMed |
| HDAC11 interacts with the NuRD (MTA3) complex to transcriptionally suppress TGFβ1 expression and inhibit hepatocellular carcinoma metastasis. | Clin Epigenetics | 2026 | 41547814 | PubTator, text mining | PubMed |
| Corrigendum to "MiR-138 reprograms dental pulp stem cells into GABAergic neurons via the GATAD2B/MTA3/WNTs axis for stroke treatment" [Biomaterials 325 (2026) 123618]. | Biomaterials | 2026 | 41290423 | PubTator, text mining | PubMed |
| Mechanisms of MTA3 in cancer and related diseases and its clinical applications. | Front Oncol | 2025 | 41584603 | PubTator, text mining | PubMed |
| Continuous DNA Methylation Deconvolution-Based Surrogate for B-Cell Differentiation State in CLL. | bioRxiv | 2025 | 41000815 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/57504
GET https://conductscience.org/api/genes/v1/57504/patents?page=2